ISRG vs STRO · P/E 80, rev $10.06B vs rev $62.0M
Intuitive Surgical Inc (ISRG) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Intuitive Surgical Inc (ISRG) is a medical instruments & supplies company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ISRG revenue for 2025-12-31 was $10.06B. Net income was $2.86B. Revenue was up 20.5% from 2024-12-31 to 2025-12-31. ISRG currently screens at market cap $195.15B and trailing P/E 80.0.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ISRG currently screens at market cap $195.15B and trailing P/E 80.0. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ISRG and STRO stock pages for the full models.
Not investment advice.